Directin vivo observation of 5-fluorouracil release from a prodrug in human tumors heterotransplanted in nude mice: a magnetic resonance study

This publication has 10 references indexed in Scilit:

• Assignment and pH dependence of the19F-NMR resonances from the fluorouracil anabolites involved in fluoropyrimidine chemotherapy
  NMR in Biomedicine, 1999
• Synthesis of self-immolative glucuronide spacers based on aminomethylcarbamate. Application to 5-fluorouracil prodrugs for antibody-directed enzyme prodrug therapy
  Journal of the Chemical Society, Perkin Transactions 1, 1999
• Prodrugs of Anthracyclines for Use in Antibody-Directed Enzyme Prodrug Therapy
  Journal of Medicinal Chemistry, 1998
• A pharmacokinetic and pharmacodynamic study In vivo of human HT29 tumours using 19F and 31P magnetic resonance spectroscopy
  European Journal Of Cancer, 1997
• Antibody-directed enzyme prodrug therapy for cancer: its theoretical basis and application
  Molecular Medicine Today, 1995
• Fusion protein mediated prodrug activation (FMPA) in vivo
  Cell Biochemistry and Biophysics, 1994
• Molecular and functional characterisation of a fusion protein suited for tumour specific prodrug activation
  British Journal of Cancer, 1992
• Activation of prodrugs by antibody‐enzyme conjugates: a new approach to cancer therapy
  The FASEB Journal, 1990
• Antibody directed enzymes revive anti-cancer prodrugs concept
  British Journal of Cancer, 1987
• Response of a high-glucuronidase human tumour xenograft to aniline mustard
  British Journal of Cancer, 1981